Study: GSK platelet-boosting drug effective

06/11/2007 | Reuters

GlaxoSmithKline's experimental drug eltrombopag showed positive results in patients with idiopathic thrombocytopenia purpura, increasing platelet counts and reducing bleeding, a Phase III study found.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ